VascuFirst
  • Home
  • About
  • Themes
    • Safety in Vascular Access
      • VAD Insertion
      • Care & Maintenance
    • Safety in HD Administration
    • Clinical Environment & History
    • Devices
      • Midlines
      • PICCs
      • Ports & Huber Needles
      • CVCs
      • Guidance Technologies
  • Guidelines
  • Events
    • Webinars
    • Congresses
  • Contact
Select Page
Combining aesthetics and feasibility in PICC-port placement

Combining aesthetics and feasibility in PICC-port placement

by Diane Weber | Mar 24, 2022 | Ports and Huber Needles

Recommendations of Dr Diane Weber, Vascular Surgeon   The clinical study on breast cancer patients has reported a very low incidence of PICC-port failure (2.6%), similar to the figures reported for chest-ports. (1) Therefore, PICC-ports are safe, and their use is...
Peripheral vascular access of elderly patients: what are the available options?

Peripheral vascular access of elderly patients: what are the available options?

by VascuFirst | Feb 23, 2022 | Midlines, PICCs, VAD Insertion

The data are unequivocal and indicate that we are heading towards an overall more elderly population. With a life expectancy in Europe of around 81.3 years and a reduction in the number of births, in the coming years, the population aged over 65 will have an important...
Acute Vascular Injuries during CICC placements

Acute Vascular Injuries during CICC placements

by Herve Rosay | Jan 25, 2022 | PICCs, Ports and Huber Needles, VAD Insertion

  Photo 1: Case Report   Introduction   Central venous catheterization (CVC) is a technique commonly used to obtain short and long-term vascular access. There are many potential risks associated with CVC insertion and that can lead to vascular injuries....

Tag Cloud

Care and Maintenance Clinical Environment and History CVCs Guidance Technologies Midlines PICCs Ports and Huber Needles Safety in HD Administration VAD Insertion Vidéo

Legal Mentions

Cookies Policy

Contact us

Campus Vygon – Vygon Spain

Follow Us

  • Twitter
  • Instagram
  • Facebook
 

Loading Comments...